Brynjelsen Sean's Form 4 filing
Eton Pharmaceuticals, Inc. (ETON) · filed May 29, 2026
- Accession no.
- 0001437749-26-018879
- Filed
- May 29, 2026
- Trade date
- May 28, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.83M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brynjelsen SeanCIK 0001669976 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | SSaleDisposed | −119,852 | $31.88 | −$3,820,881.76 | 833,842 | Direct | |
| May 28, 2026 | Common Stock | SSaleDisposed | −148 | $32.67 | −$4,835.16 | 833,694 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.